• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Tandem Diabetes Care, Inc. - Common Stock (NQ:TNDM)

    14.00 -0.59 (-4.04%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 31, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Tandem Diabetes Care, Inc. - Common Stock

    < Previous 1 2 3 4 5 6 7 Next >
    Tandem Diabetes Care Announces Upcoming Conference Presentations
    From Tandem Diabetes Care, Inc.
    Via Business Wire
    TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
    From The Rosen Law Firm PA
    Via GlobeNewswire
    t:slim X2™ Insulin Pump Now Available with Abbott’s FreeStyle Libre® 3 Plus Sensor in the United States
    From Tandem Diabetes Care, Inc.
    Via Business Wire
    Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation – TNDM
    From The Rosen Law Firm, P.A.
    Via Business Wire
    TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
    From The Rosen Law Firm PA
    Via GlobeNewswire
    Tandem Diabetes Care to Announce Third Quarter 2025 Financial Results on November 6, 2025
    From Tandem Diabetes Care, Inc.
    Via Business Wire
    Tandem t:slim X2 Insulin Pump Now Compatible With Lyumjev Ultra-Rapid Acting Insulin in the United States
    From Tandem Diabetes Care, Inc.
    Via Business Wire
    TNDM Investors Have Opportunity to Join Tandem Diabetes Care, Inc. Fraud Investigation with the Schall Law Firm
    From The Schall Law Firm
    Via Business Wire
    Tandem Diabetes Care Announces Publication Showing Adults With Type 2 Diabetes Benefit from Automated Insulin Delivery Regardless of C-Peptide Levels
    From Tandem Diabetes Care
    Via Business Wire
    TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
    From The Rosen Law Firm PA
    Via GlobeNewswire
    Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation – TNDM
    From Rosen Law Firm
    Via Business Wire
    Tandem t:slim Mobile App Now Authorized by Health Canada for iPhone and Android Phones
    From Tandem Diabetes Care, Inc.
    Via Business Wire
    Securities Fraud Investigation Into Tandem Diabetes Care, Inc. (TNDM) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
    From Glancy Prongay & Murray LLP
    Via Business Wire
    Tandem Diabetes Care, Inc. (TNDM) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
    From Law Offices of Howard G. Smith
    Via Business Wire
    Securities Fraud Investigation Into Tandem Diabetes Care, Inc. (TNDM) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
    From The Law Offices of Frank R. Cruz
    Via Business Wire
    Tandem Diabetes Care Issues Voluntary Medical Device Correction for Select t:slim X2 Insulin Pumps
    From Tandem Diabetes Care, Inc.
    Via Business Wire
    Tandem Diabetes Care Announces Second Quarter 2025 Financial Results and Provides 2025 Annual Guidance
    From Tandem Diabetes Care, Inc.
    Via Business Wire
    Tandem Diabetes Care Announces Upcoming Conference Participation
    From Tandem Diabetes Care, Inc.
    Via Business Wire
    Tandem Diabetes Care to Announce Second Quarter 2025 Financial Results on August 6, 2025
    From Tandem Diabetes Care, Inc.
    Via Business Wire
    Artificial Intelligence Revolutionizing Early Detection of Diabetic Retinopathy Creating a Multi-Billion Dollar Revenue Opportunity
    EQNX::TICKER_START (OTCQB:AVAI),(NYSE:ABT),(NASDAQ:DXCM),(NASDAQ:IRTC),(NASDAQ:TNDM) EQNX::TICKER_END 
    Via FinancialNewsMedia
    Topics Artificial Intelligence
    Tandem Diabetes Care Announces t:slim X2™ Insulin Pump Compatibility with Abbott’s FreeStyle Libre® 3 Plus Sensor in the United States
    From Tandem Diabetes Care, Inc.
    Via Business Wire
    Novel Diagnostic Technology Disrupting Diabetic Retinopathy Market Generating Billions in Revenue Opportunities
    EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:TNDM),(NYSE:NVO),(NASDAQ:PODD),(NYSE:MDT) EQNX::TICKER_END 
    Via FinancialNewsMedia
    Tandem Diabetes Care Announces Agreement with Abbott for Integration of Automated Insulin Delivery Systems with Future Glucose-Ketone Sensor
    From Tandem Diabetes Care, Inc.
    Via Business Wire
    Novel Diagnostic Technology Disrupting Diabetic Retinopathy Market Generating Billions in Revenue Opportunities
    From FN Media Group LLC
    Via GlobeNewswire
    Tandem Diabetes Care Announces Upcoming Conference Presentations
    From Tandem Diabetes Care, Inc.
    Via Business Wire
    Tandem Diabetes Care Announces First Quarter 2025 Financial Results
    From Tandem Diabetes Care, Inc.
    Via Business Wire
    Tandem Diabetes Care to Announce First Quarter 2025 Financial Results on April 30, 2025
    From Tandem Diabetes Care, Inc.
    Via Business Wire
    Tandem Diabetes Care Announces NEJM Publication of Positive Pivotal Study Outcomes with Control-IQ+ AID Technology in Type 2 Diabetes
    From Tandem Diabetes Care, Inc.
    Via Business Wire
    Tandem Diabetes Care Launches New Control-IQ+ Automated Insulin Delivery Technology in the United States
    From Tandem Diabetes Care, Inc.
    Via Business Wire
    Tandem Diabetes Care Announces Fourth Quarter and Full Year 2024 Financial Results and 2025 Financial Guidance
    From Tandem Diabetes Care, Inc.
    Via Business Wire
    < Previous 1 2 3 4 5 6 7 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.